MHM Magazine

A unique dual mechanism of action 1 • First-line treatment option for depression 2 • Proven safety and tolerability profile 1 • Fewer drug interactions than SSRIs 3 Live life in colour SSRI - Selective Serotonin Reuptake Inhibitor References: 1 . Andrews JM, Ninan PT, Nemeroff CB. Venlafaxine: a novel antidepressant that has a dual mechanism of action. Depress 1996;4:48-56. 2 . Osuch E, Marais A. The Pharmacological management of Depression – Update 2017. S Afr Fam Pract 2017;59(1):6-16. 3 . Stahl SM. Selecting an Antidepressant by Using Mechanism of Action to Enhance Efficacy and Avoid Side Effects. J Clin Psychiatry 1998;59(18):23-29. For full prescribing information please refer to the professional information approved by SAHPRA (South African Health Products Regulatory Authority). S5 Venlafaxine XR 37,5 Adco. Each extended-release capsule contains venlafaxine HCl equivalent to venlafaxine 37,5 mg. Reg. No.: 43/1.2/0577. S5 Venlafaxine XR 75 Adco. Each extended-release capsule contains venlafaxine HCl equivalent to venlafaxine 75 mg. Reg. No.: 43/1.2/0578. S5 Venlafaxine XR 150 Adco. Each extended-release capsule contains venlafaxine HCl equivalent to venlafaxine 150 mg. Reg. No.: 43/1.2/0579. S5 Venlafaxine XR 225 Adco. Each extended-release capsule contains venlafaxine HCl equivalent to venlafaxine 225 mg. Reg. No.: 52/1.2/0438. Adcock Ingram Limited. Reg. No.: 1949/034385/06. 1 New Road, Midrand, 1685. Private Bag X69, Bryanston, 2021. Tel.: +27 11 635 0000. www.adcock.com 2021041310117912. Cingulate 16619